Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026)
Amarin Corp Plcuk (AMRN) reported Revenue of $45.1 million for Q1 2026, up 7.41% year-over-year from $42.0 million in Q1 2025, and down 8.3% quarter-over-quarter from $49.2 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Revenue (2013 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 14 years of Revenue data on file, last reported at $45.1 million in Q1 2026.
- Revenue for Q1 2026 came in at $45.1 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $216.8 million (up 1.24% YoY), and the FY2025 annual result was $213.6 million, down 6.55% from the prior year.
- Revenue declined to $45.1 million in Q1 2026 per AMRN's latest filing, from $49.2 million in the prior quarter.
- Over five years, Revenue peaked at $94.6 million in Q1 2022 and troughed at $42.0 million in Q1 2025.
- A 5-year average of $68.4 million and a median of $67.5 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2025: Revenue slumped 38.87% in 2022, then climbed 17.43% in 2025.
- A 5-year view of Revenue shows it stood at $90.2 million in 2022, then dropped by 17.21% to $74.7 million in 2023, then decreased by 16.61% to $62.3 million in 2024, then declined by 21.0% to $49.2 million in 2025, then fell by 8.3% to $45.1 million in 2026.
- Business Quant data shows AMRN's Revenue at $45.1 million in Q1 2026, $49.2 million in Q4 2025, and $49.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 10.29 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 19.80 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 24.06 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 15.00 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 11.49 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | 45.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.13 Mn |
| Dec 31, 2025 | 49.22 Mn |
| Sep 30, 2025 | 49.67 Mn |
| Jun 30, 2025 | 72.74 Mn |
| Mar 31, 2025 | 42.02 Mn |
| Dec 31, 2024 | 62.31 Mn |
| Sep 30, 2024 | 42.30 Mn |
| Jun 30, 2024 | 67.49 Mn |
| Mar 31, 2024 | 56.52 Mn |
| Dec 31, 2023 | 74.71 Mn |
| Sep 30, 2023 | 66.06 Mn |
| Jun 30, 2023 | 80.17 Mn |
| Mar 31, 2023 | 85.98 Mn |
| Dec 31, 2022 | 90.25 Mn |
| Sep 30, 2022 | 89.88 Mn |
| Jun 30, 2022 | 94.44 Mn |
| Mar 31, 2022 | 94.63 Mn |
| Dec 31, 2021 | 144.49 Mn |
| Sep 30, 2021 | 142.04 Mn |
| Jun 30, 2021 | 154.49 Mn |